Jan 23 2013 | 9:09 AM

NYSE Euronext inaugurated the Retail Matching Facility, a liquidity programme that allows individual investors to benefit from the best prices for their transactions, on its European markets end of January. The goal is to retain and strengthen private investor flows in a context of fragmented liquidity.

This fragmentation follows the application of the MIF Directive in Europe, which opened up competition between markets. In practice, brokers are not always able to offer their customers access to the best European prices despite the requirements placed on them.

The Retail Matching Facility makes it possible for brokers to direct all orders  from individual investors to the Central Limit Order book where, thanks to a dedicated programme, liquidity providers certified by NYSE Euronext offer price improving...

Lees Meer
Jan 23 2013 | 9:03 AM

NYSE Euronext was partner to the 12th edition of the Deloitte Technology Fast 50, organized by Deloitte and In Extenso in France and Benelux. In France, the closing ceremony on 26 November at Palais Brongniart in Paris revealed the national winners and awarded top honors to ProwebCE, a leading company in services for labor councils listed on NYSE Alternext since 2010, for its 1,110% growth over five years.

The following listed companies were recognized:

  • ProwebCE (Levallois-Perret, Paris region), Ile-de-France and national winner
  • ConcoursMania (Bordeaux), South-West regional winner
  • Generix (Villeneuve-d'Ascq), North regional winner
  • Biosynex (Eckbolsheim), East regional winner
  • ...
Lees Meer
Jan 23 2013 | 9:02 AM

NYSE Euronext’s European Cash markets, including NYSE Arca Europe and SmartPool Trading Limited will be open Monday to Friday through 2013 except for six holidays.

  • Tuesday 1 January 2013 (New Year’s Day)
  • Friday 29 March 2013 (Good Friday)
  • Monday 1 April 2013 (Easter Monday)
  • Wednesday 1 May 2013 (Labour Day)
  • Wednesday 25 December 2013 (Christmas Day)
  • Thursday 26 December 2013 (Boxing Day)

On Tuesday 24 December 2013 and Tuesday 31 December 2013, trading on the Cash markets will close at 14:00 CET.

Further information is available at www.nyx.com/holidays-and-hours.  

Lees Meer
Jan 23 2013 | 9:01 AM

The US group Abbott Laboratories split into two entities on 2 January, and decided to list its pharmaceutical arm, renamed AbbVie, on NYSE Euronext in Paris and in New York. For each Abbott share they own, shareholders received one share of AbbVie, valuing the entity at approximately $53 billion.

The transaction aims to create new momentum for each group entity. Abbott is keeping its generic medication, dietary product and medical device businesses, which represent earnings of $22 billion. AbbVie will develop the medical and biotech research activities, and have ownership of a portfolio of brand-name medications representing around $18 billion in revenue.

Abbott was previously listed on the New York Stock Exchange and the London Stock Exchange. The group is now opting to list AbbVie on the NYSE and on NYSE Euronext in Paris, preferred over the LSE for its European listing. To do so the company will take advantage of the rapid and cost-...

Lees Meer